Workflow
Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain
默克默克(US:MRK) Investors·2025-10-30 21:43

TRENDING: You Don't Have To Dig Far To Cash In On Rare Earths Dow Jones stock Merck (MRK) topped third-quarter forecasts on Thursday, but shares skidded as its challenges with vaccine Gardasil continued. Gardasil demand is sliding in China. In total, sales of the human papillomavirus vaccine tumbled 24% to 1.75billion.Thatjustbeatforecastsfor1.75 billion. That just beat forecasts for 1.72 billion. Excluding China, sales declined just 2%. Merck widely beat third-quarter expectations and raised its 2025 profit guidance. But the company also n ...